- Home
- MCK
as 07-26-2024 4:00pm EST
McKesson Corp is one of three leading pharmaceutical wholesalers in the us engaged in sourcing and distributing branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with Cencora and Cardinal Health, the three account for over 90% of the us pharmaceutical wholesale industry. Outside the us market, McKesson engages in pharmaceutical wholesale and distribution in Canada. Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
| Founded: | 1833 | Country: | United States |
| Employees: | N/A | City: | IRVING |
| Market Cap: | 75.2B | IPO Year: | N/A |
| Target Price: | $599.29 | AVG Volume (30 days): | 647.5K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 14 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 22.39 | EPS Growth: | -10.55 |
| 52 Week Low/High: | $395.30 - $612.17 | Next Earning Date: | 08-07-2024 |
| Revenue: | $308,951,000,000 | Revenue Growth: | 11.65% |
| Revenue Growth (this year): | 17.49% | Revenue Growth (next year): | 8.31% |
Stock Insider Trading Activity of McKesson Corporation (MCK)
| Name | Ticker | Relationship | Date | Transaction | Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| TYLER BRIAN S. | MCK | Chief Executive Officer | Jul 3 '24 | Sell | $580.92 | 3,753 | $2,180,192.76 | 86,092 | SEC Form 4 |
| Martinez Maria | MCK | Director | Jun 7 '24 | Sell | $585.88 | 483 | $282,978.59 | 0 | SEC Form 4 |
| TYLER BRIAN S. | MCK | Chief Executive Officer | Jun 5 '24 | Sell | $574.41 | 3,753 | $2,155,760.73 | 89,845 | SEC Form 4 |
| Rodgers Thomas L | MCK | EVP, Chief Strategy & BDO | May 31 '24 | Sell | $560.99 | 5,232 | $2,935,099.68 | 2,544 | SEC Form 4 |
| Rodgers Thomas L | MCK | EVP, Chief Strategy & BDO | May 24 '24 | Sell | $557.40 | 789 | $439,788.60 | 7,909 | SEC Form 4 |
| Rodgers Thomas L | MCK | EVP, Chief Strategy & BDO | May 24 '24 | Sell | $550.00 | 133 | $73,150.00 | 7,776 | SEC Form 4 |
| Smith LeAnn B | MCK | EVP & Chief HR Officer | May 24 '24 | Sell | $557.40 | 206 | $114,824.40 | 2,824 | SEC Form 4 |
| Smith LeAnn B | MCK | EVP & Chief HR Officer | May 24 '24 | Sell | $550.00 | 202 | $111,100.00 | 2,622 | SEC Form 4 |
| SALKA SUSAN R | MCK | Director | May 10 '24 | Sell | $558.04 | 606 | $338,170.97 | 0 | SEC Form 4 |
| TYLER BRIAN S. | MCK | Chief Executive Officer | Mar 15 '24 | Sell | $524.55 | 3,473 | $1,821,762.15 | 43,445 | SEC Form 4 |
| Rutledge Napoleon B JR | MCK | SVP, Controller & CAO | Mar 1 '24 | Sell | $529.99 | 190 | $100,698.12 | 887 | SEC Form 4 |
| Smith LeAnn B | MCK | EVP & Chief HR Officer | Feb 13 '24 | Sell | $496.00 | 186 | $92,256.00 | 1,511 | SEC Form 4 |
| TYLER BRIAN S. | MCK | Chief Executive Officer | Jan 3 '24 | Sell | $480.00 | 10,118 | $4,856,640.00 | 43,445 | SEC Form 4 |
| TYLER BRIAN S. | MCK | Chief Executive Officer | Jan 3 '24 | Sell | $480.00 | 3,908 | $1,875,840.00 | 43,445 | SEC Form 4 |
| Smith LeAnn B | MCK | EVP & Chief HR Officer | Nov 3 '23 | Sell | $461.26 | 660 | $304,431.60 | 1,325 | SEC Form 4 |
Latest McKesson Corporation News
MCK Breaking Stock News: Dive into MCK Ticker-Specific Updates for Smart Investing
Zacks
7 hours ago
Revvity (RVTY) to Report Q2 Earnings: What's in the Cards?
Zacks
12 hours ago
Lower Volume Likely to Hurt GE HealthCare's (GEHC) Q2 Earnings
Zacks
a day ago
Factors Setting the Tone for Ecolab's (ECL) Q2 Earnings
Zacks
a day ago
McKesson Corporation (MCK) Is a Trending Stock: Facts to Know Before Betting on It
Zacks
3 days ago
McKesson (MCK) Increases Despite Market Slip: Here's What You Need to Know
Zacks
3 days ago
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
MT Newswires
3 days ago
Jefferies Adjusts Price Target on McKesson to $670 From $620, Maintains Buy Rating
Zacks
4 days ago
CGM Sensor Demand Likely to Drive DexCom (DXCM) Q2 Earnings
Compare MCK vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "MCK McKesson Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.